Skip to main content

Gene Therapy for Malignant Glioma Patients

  • Chapter
Gene Therapy of Cancer

Abstract

The development of current treatment strategies have failed to improve the prognosis of malignant glioma patients1. Consenquently, gene therapy has been suggested as a novel approach to treat these seriously ill patients2–5.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ammirati M, Galicich JH, Arbit E, Liao Y (1987): Reoperation in the treatment of recurrent intracranial malignant gliomas. Neurosurgery 21:607–614.

    Article  PubMed  CAS  Google Scholar 

  2. Culver KW, Blaese RM (1994): Gene therapy for cancer. TIG 10:174–178.

    Article  PubMed  CAS  Google Scholar 

  3. Oldfield EH, Ram Z, Culver KW, Blaese RM, Devroom HL, Anderson WF (1993):Gene therapy for the treatment of brain tumors using intratumoral transduction with the thymidine kinase gene and intravenous ganciclovir. Hum Gene Ther 4:39–69.

    Article  PubMed  CAS  Google Scholar 

  4. Ram Z, Culver K, Oshiro E, et al (1995): Summary of results and conclusions of the gene therapy of malignant brain tumors: clinicl study. (Abstract). The 63rd Annual Meeting of the American Association of Neurological Surgeons, April 22–27, 1995, Orlando, USA.

    Google Scholar 

  5. Ylä-Herttuala S (1997): Gene therapy for cancer. In:Tumor Invasion: Biological, Clinical and Therapeutical Considerations. Eds. Mikkelsen, Bjerkvig, Laerum, Rosenblum, John Wiley & Sons. (In print).

    Google Scholar 

  6. Moolten FL (1994): Drug sensitivity (“suicide”) genes for selective cancer chemotherapy. Cancer Gene Ther. 1(4):279–287.

    PubMed  CAS  Google Scholar 

  7. Thorsen F, Visted T, Lehtolainen P, Ylä-Herttuala S, Bjerkvig R (1997): Virus Production in a Replication Deficient Retrovirus Packaging Cell Line. Int. J. Cancer. (Accepted).

    Google Scholar 

  8. Yee JK, Miyanohara A, LaPorte P, Bouic K, Burns JC, Friedmann T (1994): A general method for the generation of high-titer, pantropic retroviral vectors: Highly efficient infection of primary hepatocytes. Proc. Natl. Acad. Sci. USA 91:9564–9568.

    Article  PubMed  CAS  Google Scholar 

  9. Poptani H, Puumalainen AM, Gröhn O, Loimas S, Kainulainen R, Ylä-Herttuala S, Kauppinen R: Monitoring Thymidine kinase and Ganciclovir-Induced Changes in Rat Malignant Glioma In Vivo by Nuclear Magnetic Resonance Imaging. Cancer Gene Therapy. Accepted.

    Google Scholar 

  10. Puumalainen AM, Turunen M, Loimas S, Vainio P, Vanninen R, Tyynelä K, Jänne J, Vapalahti M, Ylä-Herttuala S (1997): Thymidine kinase gene therapy and bystander effect in experimental rat glioma model in vivo. (Submitted).

    Google Scholar 

  11. Puumalainen AM, Vapalahti M, Agrawal R, Laukkanen J, Kossila M, Viita H, Vanninen R, Paljärvi L, Ylä-Herttuala S (1997): b-galactosidase gene transfer to human malignant glioma using retro- and adenovirus vectors. (Submitted).

    Google Scholar 

  12. Ylä-Herttuala S, Luoma J, Viita H, Hiltunen T, Sisto T, Nikkari T (1995): Transfer of 15-lipoxygenase gene into rabbit iliac arteries results in the appearance of oxidation-specific lipid-protein adducts characteristic of oxidized low density lipoprotein. J Clin Invest 95:2692–2698.

    Article  PubMed  Google Scholar 

  13. Bi WL, Parysek LM, Warnick R, Stambrook PJ (1993): In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSVtk retroviral gene therapy. Hum.Gene Ther. 4:725–731.

    Article  PubMed  CAS  Google Scholar 

  14. Laitinen M, Pakkanen T, Donetti E, et al. (1997): Gene transfer into the carotid artery using an adventitial collar. Human Gene Therapy 8:1657–1661.

    Google Scholar 

  15. Laitinen M, Zachary I, Breier G, Pakkanen T, Häkkinen T, Luoma J, Abedi H, Risau W, Soma M, Laakso M, Martin JF, Ylä-Herttuala S (1997): VEGF gene transfer reduces intimai thickening via increased production of nitric oxide in carotid arteries. Human Gene Therapy. In press.

    Google Scholar 

  16. Ram Z, et al. (1994): In vivo transfer of the human interleukin-2 gene: negative tumoricidal results in experimental brain tumors. J Neurosurg. 80:535–540.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media New York

About this chapter

Cite this chapter

Puumalainen, AM., Vapalahti, M., Ylä-Herttuala, S. (1998). Gene Therapy for Malignant Glioma Patients. In: Walden, P., Trefzer, U., Sterry, W., Farzaneh, F., Zambon, P. (eds) Gene Therapy of Cancer. Advances in Experimental Medicine and Biology, vol 451. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-5357-1_78

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-5357-1_78

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-7444-2

  • Online ISBN: 978-1-4615-5357-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics